Don Lenc retweeted
🎬And that’s a wrap!🎬
Congratulations to all of the speakers at #NCSAUA26, what an incredible program!
We enjoyed highlighting all of the great #OhioUrology from Maui! 🌴☀️
Happy 100th, @NCSAUA 👏👏
@AmerUrological @OSU_Urology @CleClinicUro @CaseUrology @CleClinicUroRes
Don Lenc retweeted
We had a great time attending the 💯th Annual Meeting of the North Central Section of the AUA in Maui, HI, this week 🌴☀️ What a great opportunity to highlight some of our fantastic presenters, research, and talks #OhioUrology! @NCSAUA @AmerUrological
Don Lenc retweeted
This #BreastCancerAwarenessMonth, we’re highlighting research exploring how multimodal AI can provide insights into risk and treatment benefit in early-stage breast cancer.
▪️ ASCO 2026: buff.ly/E3nQcvw
▪️ SABCS 2025: buff.ly/Rpcez3X
Don Lenc retweeted
Come learn how @TunaBeksac delivers cutting edge care at @CleClinicUro as technology evolves and integrates into our practices! Highly recommend hearing from this tremendous surgeon, person, and thinker who I am lucky to call a partner! @NCSAUA #NCSAUA26 @AmerUrological
We’re highlighting our #OhioUrology speakers at #NCSAUA26 in Maui 🌴
This morning, catch @tunabeklevic from @CleClinicUro on the Prostate Cancer Panel beginning at 7 AM!
👇👇👇👇👇
Don Lenc retweeted
👏👏🔥🔥
Faculty member Dr. Akshay Sood @Sood11 and @OhioStateMed student Tae-Hee Kim @taeheekim406 ROCKED the Adrenal/Kidney/Ureter Malignant Podium Session this morning. Great work! 🪨👏 #NCSAUA26
@NCSAUA @OhioUroSociety @OSUWexMed @OSUCCC_James
ALT Dr Sood presents at the podium
ALT Tae Hee presents at the podium
Don Lenc retweeted
We’re highlighting our #OhioUrology speakers at #NCSAUA26 in Maui 🌴
Happening now! Dr. Akshay Sood (@Sood11) from @OSU_Urology discusses “Sequence of Intravesical Therapies, Costs, and Patient Outcomes in High-Risk NMIBC”
👇👇👇👇👇
Don Lenc retweeted
How can AI help personalize #cancer treatment?
Artera CEO Andre Esteva shares his perspective on treatment selection, clinical validation, expanding access and what it takes to translate AI innovation into real-world cancer care.
Read more: buff.ly/8Y42PLn
Don Lenc retweeted
Fantastic overview of cribriform and IDC prostate cancer by our very own @ruimmbernardino
Congrats 🎉 @CleClinicUro @ricautor @drjkaouk @JaneNguyen44
Our multicentre review in Nature Reviews Urology addresses an important topic: IDC and cribriform #ProstateCancer - aggressive patterns often missed on biopsy, with major implications for risk stratification and treatment.
rdcu.be/27xcFzpbzLPa
Don Lenc retweeted
More opportunities to connect with the Artera team this October!
Find us at the Urological Surgeons of Northern California Meeting and the 100th Annual Meeting of the @AmerUrological North Central Section.
#ArteraOnTheGo
Don Lenc retweeted
This #BreastCancerAwarenessMonth, we’re highlighting progress toward more personalized care.
As our understanding of breast cancer grows, AI and precision medicine can provide deeper insights to help match the right treatment to the right patient at the right time.
Don Lenc retweeted
From localized to metastatic #ProstateCancer, where can AI-based biomarkers help inform care?
This @Medscape feature explores the growing clinical evidence behind #ArteraAI across the prostate cancer care continuum and beyond.
Read more: buff.ly/QZPlToC
Don Lenc retweeted
That’s a wrap on #ASTRO26!
Thank you to everyone who connected with the Artera team throughout the meeting. We enjoyed the conversations and the opportunity to spend time with the radiation oncology community.
Until next year!
#ProstateCancer #RadiationOncology #ArteraOnTheGo
Don Lenc retweeted
Arterans got moving for #ProstateCancerAwarenessMonth!
For our second annual Virtual Walk, the team walked and ran to raise awareness and support @ZEROCancer, with Artera donating $5 for every mile completed.
Thanks to everyone who joined us!
Don Lenc retweeted
Importantly this is modern data that with a spacer gel and SBRT at 2 years 80% of men remain potent.
This is in a prospective RCT with patient reported outcomes.
🧐nerve-sparing prostate RT?
@ndesai2005 presents Poten-C trial
Unilateral NVB sparing:
❌ did not improve sexual function (primary endpoint)
🤔 urinary function better w NVB sparing
@ASTRO_org #ASTRO26
Don Lenc retweeted
🚨 A rising PSA after testosterone recovery does NOT necessarily mean metastatic progression. @Soum_Roy_RadOnc delivers once again important data @ASTRO_org !
In 402 men with ~10 years follow-up, faster PSA kinetics strongly predicted progression—but had no association with distant metastasis on cause-specific analysis (HR 1.00).
PSA ≠ metastasis.
#ASTRO26 @AmarUKishan @urotoday @rtdess @angela_jia_ @DrChoueiri @AarmstrongDuke @ChrisSweens1 @jamesbyu @HimanshuNagarMD @alison_tree @TylerSbrt
Don Lenc retweeted
We’re kicking things off this Oct. 1–3 at the @GRUrology Innovations in Urologic Practice and the @mecmededucation Advances in Oncology Conference.
See where else you can find us throughout October. 👇
#ProstateCancer #Urology #Oncology #ArteraOnTheGo
Don Lenc retweeted
In case you missed it: research showing that multimodal AI predicts abiraterone benefit in very high-risk #ProstateCancer is heading to print in the October issue of Annals of Oncology.
Read the full publication: buff.ly/zkVMcnp
#ArteraAI
Don Lenc retweeted
Our pathologists guide the way! @therapy_focal meeting @dr_coops highlights the blockbuster work of @JaneNguyen44 @ClevelandClinic showing that path solidly predicts outcomes in prostate cancer. Zero deaths or mets after decades of follow up in the setting of favorable histology!
